Abstract:The Asia-Pacific shares moves lower around a sluggish session. The Hopes of faster tapering, Fed rate hike battles Omicron woes to challenge momentum traders.
The Asia-Pacific shares moves lower around a sluggish session. The Hopes of faster tapering, Fed rate hike battles Omicron woes to challenge momentum traders.
Asian equities continues to lacks lackluster, mostly downbeat, during early Wednesday morning in Europe as markets brace for the key Federal Open Market Committee (FOMC).
Which is to say, the MSCI‘s index of Asia ex-Japan drops 0.11% whereas Japan’s Nikkei 225 prints 0.05% intraday gains by the press time.
Unpleasant emotions of the Fed‘s end to bond purchase, followed by a rate hike, join the Omicron woes to challenge the equity buyers. Moreover, the US passage of a bill to raise the debt limits and President Joe Biden’s push for getting his Build Back Better (BBB) plan through the House in 2021 keep buyers hopeful. Additionally, Pfizers announcements concerning the efficacy of its vaccines and medicines over the South African covid variant, dubbed as Omicron, also defend the bulls.
It‘s reasonable to note that escalating fears over China’s financial markets and mixed data at home, weigh on the stocks from Beijing. On the same line is the news that the US House passes Uyghur Bill aimed at China. Drowning with Chinese securities are stocks from Australia, New Zealand and Hong Kong. On the same line is India‘s BSE Sensex and South Korea’s KOSPI. It should be observed that the record covid cases in South Korea, per Reuters, offer additional downside pressure on the KOSPI.
On the opposite direction, markets in Indonesia print mild gains amid receding trade balance whereas the Bank of Japan‘s liquidity infusion and a lack of major negatives concerning the virus seem to help stocks from Tokyo to remain firm. On a broader front, the US Treasury yields and the S&P 500 Futures remain sluggish while the Wall Street benchmarks closed negative the previous day. It is important to know that, the Fed’s action will be crucial for near-term market directions as equity bears have high hopes from the Fed hawks.
Is TriumphFX a trustworthy broker or a scam in 2025? This review explores its regulation, withdrawal issues, and more to help you decide if it's a safe bet or a risky trap.
In an industry where safety and transparency are paramount, the regulatory status of online brokers has never been more important. For traders seeking to protect their capital, ensuring that a platform operates under recognised and stringent oversight can make all the difference. Vantage Markets, a well-known name in the online trading space, has recently come under review. Keep reading to learn more about Vantage Markets and its licenses.
Spreadex, a UK-based provider of spread betting and CFD trading services, has introduced a promotional offer for new clients. Individuals who open a live trading account and deposit at least £500 will receive a six-month digital subscription to the Financial Times.
HYCM underwent a major leadership and structural shift in 2024 with a £1.4 million management buyout and the sale of its Dubai unit